Norma Harte, Patient Representative, Dr Fionnuala Keane, Chief Operating Officer of HRB CRCI and Prof Geraldine Boylan, Professor of Neonatal Physiology UCC and Director of Infant celebrating International Clinical Trials Day at the Mansion House today and commemorating the anniversary of the first clinical trial which took place in 1747, assessing the benefit of citrus fruits as a treatment for scurvy in sailors.

Norma Harte, Patient Representative, Dr Fionnuala Keane, Chief Operating Officer of HRB CRCI and Prof Geraldine Boylan, Professor of Neonatal Physiology UCC & Director of Infant celebrating International Clinical Trials Day at the Mansion House today.

Ireland has tremendous potential to increase its international reputation as a clinical research hub and attract more research projects which provide many benefits for Irish patients, if there is continued focus on enhancing clinical research infrastructure in Ireland, some 200 delegates heard today at a national seminar to mark International Clinical Trials Day 2017. The HRB-CRCI (Health Research Board Clinical Research Coordination Ireland) seminar, “Improving Patient Health Through Clinical Research”, brought together some of Ireland’s leading experts involved in clinical research in Ireland as well as patients to highlight how improved access to clinical trials can increase health benefits for patients. The HRB-CRCI outlined that investment in Irish clinical infrastructure is showing progress with 197 trial sites now opened across its research centres in Ireland in 2016 compared to 143 in 2014.

  • There has been a 37 percent increase in the number of clinical trial sites* since 2014
  • Over 134 international clinical trial study queries processed through HRB-CRCI, with over 111 assessments processed
  • Almost 300 Irish doctors seeking support through the clinical research facilities and centres nationwide to undertake clinical research in Ireland

Since 2014, there has been a 37 percent increase in the number of sites conducting clinical research in Ireland and over 134 international clinical trial study queries have been centrally processed for potential opportunity. The HRB-CRCI states that in 2016 there were 15 hospitals and almost 300 clinical investigators involved in clinical research in Ireland working with the clinical research facilities and centres around the country. Each year over the past number of years over 100 new clinical trials have opened in Ireland.

According to Dr Mairead O’Driscoll, Interim Chief Executive at the Health Research Board, “The HRB took a very deliberate and strategic approach to developing the clinical research ecosystem in Ireland. Our investments in the physical infrastructures, the researchers, and the research networks have been the springboard to this upsurge in clinical trials activity in our health system. And between now and the end of our current strategy in 2020, we plan to invest a further €54 million to maintain and to expand Ireland’s capacity to conduct clinical trials and healthcare intervention studies.”

Deirdre Glenn, Director Lifesciences and Food, Enterprise Ireland said: “As a funder of the HRB-CRCI, Enterprise Ireland recognises the need to bolster the Clinical Trial infrastructure in Ireland and we greatly welcome the increase in the number of trial sites announced today which benefits both indigenous and multi-national companies. The life sciences and medtech sector accounts for a significant level of Irelands export revenue and today’s announcement further builds on our strong international reputation for excellence and innovation in healthcare. Through the HRB-CRCI, companies will benefit from having access to a strong national clinical research system that enables them to develop novel products and technologies in Ireland, benefitting society as a whole and confirming Ireland’s status as a global leader in healthcare solutions.”

The seminar heard from Dr Pat O’Mahony, CEO, Molecular Medicine Ireland, that creating further scale and increasing clinical research in Ireland requires stakeholders collaborating to create a permanent infrastructure that includes medium to long-term funding visibility; promoting research as a core component of careers in health service delivery; and advocating to patients the many benefits of participating in trials. “Investment in our clinical research infrastructure has shown substantial results. It has resulted in increased trials, more centres for trials around the country, and most importantly offered access to health innovations for more Irish patients. To further build on this, research must become an integral part of our overall health service delivery. In practice, this would mean enabling all interested health professionals to have the capacity to test new innovative treatments, therapies and medical devices with their patients during their daily work. It would mean greater and easier access for patients, and increased opportunities to collect research data. It would mean fundamentally increasing the clinical research scale we have in Ireland. Our ultimate aim should be that any patient who needs care, is suitable and has a desire to access novel treatments under development, could have the option to do so,” said Dr O’Mahony.

HRB-CRCI acts as a coordinating centre for Ireland’s involvement in clinical trials, promotes the Irish network internationally and Ireland’s ability to successfully deliver multicentre trials led by Irish or international investigators. “It is widely acknowledged that clinical research not only saves lives but can enhance patients’ lives in the longer term as new products come to market. Those countries that have embraced research as part of their national healthcare system have also witnessed better health outcomes for their patients. Ireland has established a research community that complies with the quality and regulatory standards required to safeguard patients whilst enabling new innovations to be efficiently tested. This infrastructure has the potential to be up scaled now to take best advantage and position Ireland as a significant hub for clinical research for the future,” said Prof Joe Eustace, Chairperson of HRB-CRCI.

Speaking about the clinical research infrastructure in Ireland, Dr Fionnuala Keane, Chief Operating Officer, HRB-CRCI, said “We need to create more awareness for Ireland as a country that can host significant research projects. Ireland has a thriving life sciences sector rooted in both academia and industry and this enriched arena provides a natural linkage to enabling clinical research. The more organised and sophisticated our clinical research infrastructure and delivery systems are, the better the outcomes will be for the public we serve. That also means we must have a long term plan and funding model to meet the needs of industry and academia wishing to host trials so that a robust network which is composed of an appropriate infrastructure, qualified personnel and clinical research skills is available here.”

Concluding Dr Keane said, “Since the first clinical trial took place in 1747, assessing the benefit of citrus fruits as a treatment for scurvy in sailors, clinical trials have come a long way. International Clinical Trials Day on Saturday 20 May is a unique opportunity to share information on the current exciting innovations taking place here and review how we can enlarge our research capacity in Ireland to the benefit of patients”.

HRB-CRCI today published a programme outlining the events taking place across the country to mark International Clinical Trials Day.

For further information on the events scheduled visit: www.hrb-crci.ie/2017/05/ictd2017_event_calender

May 15, 2017
Norma Harte, Patient Representative, Dr Fionnuala Keane, Chief Operating Officer of HRB CRCI and Prof Geraldine Boylan, Professor of Neonatal Physiology UCC and Director of Infant celebrating International Clinical Trials Day at the Mansion House today and commemorating the anniversary of the first clinical trial which took place in 1747, assessing the benefit of citrus fruits as a treatment for scurvy in sailors.

Clinical research in Ireland at a unique point for scaling up growth

Ireland has tremendous potential to increase its international reputation as a clinical research hub and attract more research projects which provide many benefits for Irish patients, […]
May 9, 2017
Fionnuala-NiAinle-web

Update on MMI Clinician Scientist Fellow Alumnus – Dr Fionnuala Ní Áinle

The MMI Clinician Scientist Fellowship Programme (CSFP) is a structured 3-year PhD programme for medical graduates with the objective of developing the next generation of clinician […]
May 8, 2017
Picture1

Career opportunity with Molecular Medicine Ireland

Molecular Medicine Ireland in partnership with CÚRAM, the Centre for Research in Medical Devices, seeks a high-calibre candidate to work in a collaborative centre of excellence […]
April 5, 2017
HRB-CRCI-Clinical-Trials-Day-2017-MMI-Blog-2

Invitation to HRB CRCI seminar on Monday 15 May 2017 to celebrate International Clinical Trials Day 2017

HRB CRCI invites you to a seminar Improving Patient Health Through Clinical Research on Monday 15 May 2017 to celebrate International Clinical Trials Day 2017. The […]
March 30, 2017

Clinical Research Fellow post available at Queen’s University Belfast

Job Title: Clinical Research Fellow Ref: 17/105413 
Application Closing Date: 24/04/2017 Anticipated Interview Dates: Thursday 18 and Friday 19 May 2017 Salary: £31,614 to £47,647 per […]
March 30, 2017
12345

Update on MMI Clinician Scientist Fellow Alumnus – Dr Sanjay Haresh Chotirmall

The MMI Clinician Scientist Fellowship Programme (CSFP) is a structured 3-year PhD programme for medical graduates with the objective of developing the next generation of clinician […]
March 24, 2017
PosterPatientVoiceIII_poster

UCD The Patient Voice in Cancer Research III

Date: Wednesday, 12 April 2017 Venue: UCD Charles Institute, University College Dublin Free registration is now open for the third event in this series, UCD The […]
March 24, 2017
HRB-CRCI Clinical Trial Liaison Officer

HRB CRCI seeks Clinical Trial Liaison Officer

Post Title: Clinical Trial Liaison Officer, HRB Clinical Research Coordination Ireland Post Status: Fixed term contract until 31 December, with possible extension Organisation: Molecular Medicine Ireland Location: Molecular Medicine Ireland […]
March 23, 2017
Professor Abhay Pandit

Prof Abhay Pandit from CÚRAM featured in The Irish Times

An interview of Prof Abhay Pandit, scientific director of the Centre for Research in Medical Devices (CÚRAM), the SFI Centre for Research in Medical Devices, and […]
March 6, 2017
MMI-news-image-Fiona-Cregg

Fiona Cregg appointed as Quality and Regulatory Affairs Manager of HRB CRCI

Fiona Cregg has been appointed to the role of Quality and Regulatory Affairs Manager (QRAM) with the HRB CRCI  based at MMI. Fiona began her career as a Research […]